ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

The GOOD and the BAD Side of GLP-1s and What to Do If You Get Caught…

Ken Fujioka

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Cardiogenic Shock - The Team Approach

Faisal Rahman

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Beyond 10-Year Risk: New Paradigms for Long-Term Risk Estimation Wit…

Heart in Diabetes (HiD)

S. Khan

Review of Coronary Artery Calcium Testing for Primary Care

Dr. Catherine P. Benziger

C. Benziger

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonist…

Alessandro Doria

Chest Pain in Emergency Department Settings

University Hospitals

G. Rao, R. Hughes

Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…

Houston Methodist

T. R. Mccarty

New Research: Side Effect of GLP1

Susan Brian

RV Function on 2D Echo

Rabia Arshad

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

An Efficient Approach to Addressing Syncope in the Office

Dr. Vu Kiet Tran

V. Tran

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann

Social Determinants of Health for Cardiovascular Kidney Metabolic Sy…

Kibret Enyew Belay

I Have a Carrot and a Stent, You Pick!

Koushik Reddy